Literature DB >> 17849398

Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding.

Luciana Marinelli1, Sandro Cosconati, Thomas Steinbrecher, Vittorio Limongelli, Alessia Bertamino, Ettore Novellino, David A Case.   

Abstract

NMDA receptors are glutamate-gated ion channels (iGluRs) that are involved in several important physiological functions such as neuronal development, synaptic plasticity, learning, and memory. Among iGluRs, NMDA receptors have been perhaps the most actively investigated for their role in chronic neurodegeneration such as Alzheimer's, Parkinson's, and Huntington's diseases. Recent studies have shown that the NTD of subunit NR2B modulates ion channel gating through the binding of allosteric modulators such as the prototypical compound ifenprodil. In the present paper, the construction of a three-dimensional model for the NR2B modulatory domain is described and docking calculations allow, for the first time, definition of the ifenprodil binding pose at an atomic level and fully explain all the available structure-activity relationships. Moreover, in an attempt to add further insight into the ifenprodil mechanism of action, as it is not completely clear if it binds and stabilizes an open or a closed conformation of the NR2B modulatory domain, a matter, which is fundamental for the rational design of NMDA antagonists, MD simulations followed by an MM-PBSA analysis were performed. These calculations reveal that the closed conformation of the R1-R2 domain, rather than the open, constitutes the high affinity binding site for ifenprodil and that a profound stabilization of the closed conformation upon ifenprodil binding occurs. Thus, for a rational design and/or for virtual screening experiments, the closed conformation of the R1-R2 domain should be taken into account and our 3D model can provide valuable hints for the design of NR2B-selective antagonists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17849398     DOI: 10.1002/cmdc.200700091

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  12 in total

Review 1.  Control of assembly and function of glutamate receptors by the amino-terminal domain.

Authors:  Kasper B Hansen; Hiro Furukawa; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2010-07-21       Impact factor: 4.436

2.  Mapping the binding of GluN2B-selective N-methyl-D-aspartate receptor negative allosteric modulators.

Authors:  Pieter B Burger; Hongjie Yuan; Erkan Karakas; Matthew Geballe; Hiro Furukawa; Dennis C Liotta; James P Snyder; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2012-05-17       Impact factor: 4.436

3.  Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit.

Authors:  Erkan Karakas; Noriko Simorowski; Hiro Furukawa
Journal:  EMBO J       Date:  2009-12-16       Impact factor: 11.598

Review 4.  In Silico Studies in Drug Research Against Neurodegenerative Diseases.

Authors:  Farahnaz Rezaei Makhouri; Jahan B Ghasemi
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  A computational modeling and molecular dynamics study of the Michaelis complex of human protein Z-dependent protease inhibitor (ZPI) and factor Xa (FXa).

Authors:  Vasudevan Chandrasekaran; Chang Jun Lee; Ping Lin; Robert E Duke; Lee G Pedersen
Journal:  J Mol Model       Date:  2009-01-27       Impact factor: 1.810

6.  Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors.

Authors:  Cara A Mosley; Scott J Myers; Ernest E Murray; Rose Santangelo; Yesim A Tahirovic; Natalie Kurtkaya; Praseeda Mullasseril; Hongjie Yuan; Polina Lyuboslavsky; Phuong Le; Lawrence J Wilson; Manuel Yepes; Ray Dingledine; Stephen F Traynelis; Dennis C Liotta
Journal:  Bioorg Med Chem       Date:  2009-07-05       Impact factor: 3.641

Review 7.  Allosteric modulators for the treatment of schizophrenia: targeting glutamatergic networks.

Authors:  Frank S Menniti; Craig W Lindsley; P Jeffrey Conn; Jayvardhan Pandit; Panayiotis Zagouras; Robert A Volkmann
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

8.  Control of NMDA receptor function by the NR2 subunit amino-terminal domain.

Authors:  Hongjie Yuan; Kasper B Hansen; Katie M Vance; Kevin K Ogden; Stephen F Traynelis
Journal:  J Neurosci       Date:  2009-09-30       Impact factor: 6.167

9.  The N-terminal domain of GluR6-subtype glutamate receptor ion channels.

Authors:  Janesh Kumar; Peter Schuck; Rongsheng Jin; Mark L Mayer
Journal:  Nat Struct Mol Biol       Date:  2009-05-24       Impact factor: 15.369

10.  Alcohol and NMDA receptor: current research and future direction.

Authors:  Raman Chandrasekar
Journal:  Front Mol Neurosci       Date:  2013-05-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.